Jessica N. Abraham | Designer. Writer. Publicist.

19+ Years of Expertise in Digital Marketing, Social Branding and Public Relations.

  • Home
  • Contact
  • About
  • Home
  • Contact
  • About

No Widgets found in the Sidebar Alt!

  • Technical advancements in stem cell therapies have reportedly shifted the outlook of regenerative medicine, and some scientists are getting increasingly excited. Cardiologist Dr. Joshua Hare is one of those scientists, and he’s both the co-founder and chief scientific officer of Longeveron Inc. (NASDAQ: LGVN), a clinical-stage biotechnology company developing cellular therapies for aging-related and life-threatening conditions. He’s also credited with helping to pioneer the use of stem cells as medicine for the human heart and regularly explores a future where regenerative medicine can prolong human life.
    Benzinga,  Biotechnology,  Health,  Nature,  Regenerative Medicine

    Should Aging Be Treated As A Disease? And How One Company Might Be Shifting The Paradigm To Reverse It

    June 15, 2022 /

    Originally Published on Benzinga Technical advancements in stem cell therapies have reportedly shifted the outlook of regenerative medicine, and some scientists are getting increasingly excited. Cardiologist Dr. Joshua Hare is one of those scientists, and he’s both the co-founder and chief scientific officer of Longeveron Inc. (NASDAQ: LGVN), a clinical-stage biotechnology company developing cellular therapies for aging-related and life-threatening conditions. He’s also credited with helping to pioneer the use of stem cells as medicine for the human heart and regularly explores a future where regenerative medicine can prolong human life. The global regenerative medicine market  is estimated to reach $6.49 billion in 2027, up 9.3% from $3.05 billion in 2019. …

    read more
    Jessica N. Abraham Comments Off on Should Aging Be Treated As A Disease? And How One Company Might Be Shifting The Paradigm To Reverse It

    You May Also Like

    Jessica Abraham, Jessica N Abraham, Benzinga, Technology, Business, Tech, Tech News, Technology News, Business News, Finance News, Invest, Investing, Education, Brands, Cannabis,

    Follow Jessica N. Abraham on Benzinga

    August 3, 2021
    VUZIX M400 Product #: 472T00011 First smart glasses with a dedicated XR1 platform Lightweight, comfortable fit that you can wear all day The only option that lets you hot swap batteries on the fly with zero interruption Increased processing power, RAM, and storage Upgraded OLED panel display and camera with higher resolution and scanning Immersive UI with native voice processing, motion tracking, and more

    Vuzix | Will the Next Big Trend in Wearables be Smart Glasses?

    June 28, 2021
    Cadiac heart monitoring

    Biotricity Invites Physicians to Join Shared Revenue Opportunity, Provides Clinics with Remote Devices for Improved Monitoring and Diagnosis

    November 11, 2021
  • Cell Transplant, Eye Transplant, Cellular Regeneration, Regeneration Therapy,
    Health,  Benzinga,  Biotechnology,  Business,  Finance,  Regenerative Medicine

    Lineage, Pioneering a New Branch of Medicine — OpRegen Continues to Show Promising Results in Dry AMD with Geographic Atrophy

    October 21, 2021 /

    Previously Published on Benzinga: The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of Benzinga. Lineage Cell Therapeutics Inc. (AMEX: LCTX) recently provided an update on its lead program OpRegen®, a cell replacement therapy for dry age-related macular degeneration (AMD) with geographic atrophy (GA).  Lineage is pioneering a new branch of medicine, which is manufacturing differentiated cell types and transplanting those cells into the body, to restore or improve function which has been lost due to injury or disease.  The data from an ongoing Phase 1/2a clinical study continued to demonstrate that a single administration of OpRegen, an investigational cell therapy consisting of…

    read more
    Jessica N. Abraham Comments Off on Lineage, Pioneering a New Branch of Medicine — OpRegen Continues to Show Promising Results in Dry AMD with Geographic Atrophy

    You May Also Like

    industrial Hemp, Generation Hemp, GENH, Hemp, Cannabis, Textiles, Manufacturing,

    Why Is There a Renewed Interest in Hemp by Textile and Manufacturing Companies?

    August 6, 2021
    Generation Hemp is a Pure-Play industrial hemp company that focuses on providing sustainability within the industrial hemp sector.

    Is Generation Hemp Now A Leader in Pure-Play Hemp Operations for the Industrial Sector?

    October 28, 2021
    MedTech, HealthTech, Benzinga, BioSig Technologies, BioPharmaceuticals, Jessica Abraham, Jessica N Abraham,

    MedTech Company BioSig Technologies Deploys Disruptive Technology To Improve Arrhythmia Care

    April 7, 2022
  • Business
  • Technology
  • Career Development
  • Education
  • Entertainment
  • Fashion
  • Relationships
  • Tips
  • Travel
Ashe Theme by WP Royal.